DeepMed Research

SAR-405838

Generic Name: SAR-405838

Drug Type: Small Molecule

Chemical Formula: C_₂₉H_₃₄Cl_₂FN_₃O_₃

CAS Number: 1303607-60-4

Unique Ingredient Identifier: 8570LZ3RCA

Background: SAR405838 has been used in trials studying the treatment of Neoplasm Malignant.

Clinical Trials

A Safety and Efficacy Study of SAR405838 and Pimasertib in Cancer Patients

Phase 1

Completed

Conditions: Neoplasm Malignant

Interventions: Drug: SAR405838
Drug: Pimasertib

First Posted Date: 2013-11-15

Last Posted Date: 2016-02-25

Lead Sponsor: Sanofi

Target Recruit Count: 26

Registration Number: NCT01985191

Locations: 🇳🇱
Investigational Site Number 528002, Utrecht, Netherlands
🇫🇷
Investigational Site Number 250001, Villejuif Cedex, France
🇳🇱
Investigational Site Number 528003, Rotterdam, Netherlands

and more 1 locations

Phase 1 Safety Testing of SAR405838

Phase 1

Completed

Conditions: Neoplasm Malignant

Interventions: Drug: SAR405838

First Posted Date: 2012-07-10

Last Posted Date: 2018-05-17

Lead Sponsor: Sanofi

Target Recruit Count: 77

Registration Number: NCT01636479

Locations: 🇺🇸
Investigational Site Number 840101, Boston, Massachusetts, United States
🇺🇸
Investigational Site Number 840001, Boston, Massachusetts, United States
🇺🇸
Investigational Site Number 840002, New York, New York, United States

and more 4 locations

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy